Kaplan Fox Urges Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Before the Securities Class Action Deadline on November 2, 2026

Impact · against what's priced in

The announcement of the class action lawsuit is a non-event for HIMS shareholders. The market has already baked in significant legal friction and the lack of a clean resolution to existing litigation into the current valuation.

HIMS−0.05

Already priced in

The price assumes

Significant legal and regulatory friction, including FTC lawsuits over data privacy and billing practices.